Literature DB >> 16973580

Cellular target genes of Epstein-Barr virus nuclear antigen 2.

Sabine Maier1, Gabriele Staffler, Andrea Hartmann, Julia Höck, Karen Henning, Kristina Grabusic, Reinhard Mailhammer, Reinhard Hoffmann, Matthias Wilmanns, Roland Lang, Jörg Mages, Bettina Kempkes.   

Abstract

Epstein-Barr virus (EBV) nuclear antigen 2 (EBNA-2) is a key determinant in the EBV-driven B-cell growth transformation process. By activating an array of viral and cellular target genes, EBNA-2 initiates a cascade of events which ultimately cause cell cycle entry and the proliferation of the infected B cell. In order to identify cellular target genes that respond to EBNA-2 in the absence of other viral factors, we have performed a comprehensive search for EBNA-2 target genes in two EBV-negative B-cell lines. This screen identified 311 EBNA-2-induced and 239 EBNA-2-repressed genes that were significantly regulated in either one or both cell lines. The activation of most of these genes had not previously been attributed to EBNA-2 function and will be relevant for the identification of EBNA-2-specific contributions to EBV-associated malignancies. The diverse spectrum of EBNA-2 target genes described in this study reflects the broad spectrum of EBNA-2 functions involved in virus-host interactions, including cell signaling molecules, adapters, genes involved in cell cycle regulation, and chemokines.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16973580      PMCID: PMC1617228          DOI: 10.1128/JVI.00665-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  68 in total

1.  Epstein-Barr virus nuclear antigen 2 induces FcRH5 expression through CBF1.

Authors:  Joanne Mohan; Jessica Dement-Brown; Sabine Maier; Tomoko Ise; Bettina Kempkes; Mate Tolnay
Journal:  Blood       Date:  2006-01-26       Impact factor: 22.113

2.  Epstein-Barr virus nuclear antigen 2 (EBNA2)-oestrogen receptor fusion proteins complement the EBNA2-deficient Epstein-Barr virus strain P3HR1 in transformation of primary B cells but suppress growth of human B cell lymphoma lines.

Authors:  B Kempkes; U Zimber-Strobl; G Eissner; M Pawlita; M Falk; W Hammerschmidt; G W Bornkamm
Journal:  J Gen Virol       Date:  1996-02       Impact factor: 3.891

3.  Epstein-Barr virus nuclear antigen 2 is a transcriptional suppressor of the immunoglobulin mu gene: implications for the expression of the translocated c-myc gene in Burkitt's lymphoma cells.

Authors:  N Jochner; D Eick; U Zimber-Strobl; M Pawlita; G W Bornkamm; B Kempkes
Journal:  EMBO J       Date:  1996-01-15       Impact factor: 11.598

4.  Epstein-Barr virus nuclear antigen 2-estrogen receptor fusion proteins transactivate viral and cellular genes and interact with RBP-J kappa in a conditional fashion.

Authors:  B Kempkes; M Pawlita; U Zimber-Strobl; G Eissner; G Laux; G W Bornkamm
Journal:  Virology       Date:  1995-12-20       Impact factor: 3.616

5.  Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23.

Authors:  F Wang; C D Gregory; M Rowe; A B Rickinson; D Wang; M Birkenbach; H Kikutani; T Kishimoto; E Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

6.  Regulation of the ERBB-2 promoter by RBPJkappa and NOTCH.

Authors:  Y Chen; W H Fischer; G N Gill
Journal:  J Biol Chem       Date:  1997-05-30       Impact factor: 5.157

7.  Establishment in continuous culture of a new type of lymphocyte from a "Burkitt like" malignant lymphoma (line D.G.-75).

Authors:  H Ben-Bassat; N Goldblum; S Mitrani; T Goldblum; J M Yoffey; M M Cohen; Z Bentwich; B Ramot; E Klein; G Klein
Journal:  Int J Cancer       Date:  1977-01       Impact factor: 7.396

8.  Continuous lymphoid cell lines with characteristics of B cells (bone-marrow-derived), lacking the Epstein-Barr virus genome and derived from three human lymphomas.

Authors:  G Klein; T Lindahl; M Jondal; W Leibold; J Menézes; K Nilsson; C Sundström
Journal:  Proc Natl Acad Sci U S A       Date:  1974-08       Impact factor: 11.205

9.  The use of lymphomatous and lymphoblastoid cell lines in the study of Burkitt's lymphoma.

Authors:  G M Lenoir; M Vuillaume; C Bonnardel
Journal:  IARC Sci Publ       Date:  1985

10.  Signalling downstream of activated mammalian Notch.

Authors:  S Jarriault; C Brou; F Logeat; E H Schroeter; R Kopan; A Israel
Journal:  Nature       Date:  1995-09-28       Impact factor: 49.962

View more
  38 in total

1.  EBV nuclear antigen EBNALP dismisses transcription repressors NCoR and RBPJ from enhancers and EBNA2 increases NCoR-deficient RBPJ DNA binding.

Authors:  Daniel Portal; Bo Zhao; Michael A Calderwood; Thomas Sommermann; Eric Johannsen; Elliott Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-25       Impact factor: 11.205

2.  Differential gene regulation by Epstein-Barr virus type 1 and type 2 EBNA2.

Authors:  Walter Lucchesi; Gareth Brady; Oliver Dittrich-Breiholz; Michael Kracht; Rainer Russ; Paul J Farrell
Journal:  J Virol       Date:  2008-05-14       Impact factor: 5.103

3.  Changes in chemokines and chemokine receptor expression on tonsillar B cells upon Epstein-Barr virus infection.

Authors:  Barbro Ehlin-Henriksson; Wu Liang; Alberto Cagigi; Frida Mowafi; George Klein; Anna Nilsson
Journal:  Immunology       Date:  2009-08       Impact factor: 7.397

4.  Statin-induced changes in gene expression in EBV-transformed and native B-cells.

Authors:  Eugene Bolotin; Angela Armendariz; Kyungpil Kim; Seok-Jin Heo; Dario Boffelli; Kelan Tantisira; Jerome I Rotter; Ronald M Krauss; Marisa W Medina
Journal:  Hum Mol Genet       Date:  2013-10-30       Impact factor: 6.150

5.  Transcript origin analysis identifies antigen-presenting cells as primary targets of socially regulated gene expression in leukocytes.

Authors:  Steven W Cole; Louise C Hawkley; Jesusa M G Arevalo; John T Cacioppo
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-07       Impact factor: 11.205

Review 6.  ABHD6: Its Place in Endocannabinoid Signaling and Beyond.

Authors:  Jessica K Cao; Joshua Kaplan; Nephi Stella
Journal:  Trends Pharmacol Sci       Date:  2019-03-07       Impact factor: 14.819

7.  Epstein-Barr virus nuclear antigen 3C regulated genes in lymphoblastoid cell lines.

Authors:  Bo Zhao; Jessica C Mar; Seiji Maruo; Sungwook Lee; Benjamin E Gewurz; Eric Johannsen; Kristina Holton; Renee Rubio; Kenzo Takada; John Quackenbush; Elliott Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-20       Impact factor: 11.205

Review 8.  Mammalian alpha beta hydrolase domain (ABHD) proteins: Lipid metabolizing enzymes at the interface of cell signaling and energy metabolism.

Authors:  Caleb C Lord; Gwynneth Thomas; J Mark Brown
Journal:  Biochim Biophys Acta       Date:  2013-01-14

9.  Extensive co-operation between the Epstein-Barr virus EBNA3 proteins in the manipulation of host gene expression and epigenetic chromatin modification.

Authors:  Robert E White; Ian J Groves; Ernest Turro; Jade Yee; Elisabeth Kremmer; Martin J Allday
Journal:  PLoS One       Date:  2010-11-15       Impact factor: 3.240

10.  Differential gene expression patterns of EBV infected EBNA-3A positive and negative human B lymphocytes.

Authors:  Marie L Hertle; Claudia Popp; Sabine Petermann; Sabine Maier; Elisabeth Kremmer; Roland Lang; Jörg Mages; Bettina Kempkes
Journal:  PLoS Pathog       Date:  2009-07-03       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.